Newsroom
Sorted by: Latest
-
Samenvatting: Meiji Seika Pharma investeert in het Global Health Security Fund van GHIC
TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (hoofdkantoor: Tokio, Japan; president en vertegenwoordigend directeur: Toshiaki Nagasato) heeft vandaag bekendgemaakt dat het heeft toegezegd te investeren in het Global Health Security Fund (GHSF). Dit fonds wordt gesponsord door Global Health Investment Corporation (GHIC), een in New York gevestigde non-profitorganisatie. Met deze investering zal Meiji Seika Pharma innovaties helpen versnellen die cruciale wereldwijde gezondheidsuitdaginge...
-
Riassunto: Meiji Seika Pharma investe nel Global Health Security Fund di GHIC
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Sede centrale: Tokyo, Giappone; Presidente e Direttore rappresentante: Toshiaki Nagasato) oggi ha reso noto il proprio impegno a investire nel Global Health Security Fund (GHSF), il fondo globale per la sicurezza sanitaria, sponsorizzato da Global Health Investment Corporation (GHIC), organizzazione no-profit con sede a New York. Attraverso questo investimento, Meiji Seika Pharma promuoverà l'accelerazione delle innovazioni per affrontare le...
-
Samenvatting: BeOne Medicines stelt norm voor langdurige ziektecontrole bij CLL met BRUKINSA-gegevens van 78 maanden op ASCO 2026
SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), een wereldwijd oncologiebedrijf, vernieuwt het behandelingsparadigma voor chronische lymfatische leukemie (CLL) tijdens de jaarlijkse bijeenkomst van de American Society of Clinical Oncology (ASCO) in 2026. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal, die als enige rechtsgeldi...
-
Meiji Seika Pharma investit dans le Fonds mondial pour la sécurité sanitaire de la GHIC
TOKYO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Siège social : Tokyo, Japon ; Président-directeur général : Toshiaki Nagasato) a annoncé aujourd’hui son engagement à investir dans le Fonds mondial pour la sécurité sanitaire (GHSF), parrainé par la Global Health Investment Corporation (GHIC), une organisation à but non lucratif ayant son siège à New York. Grâce à cet investissement, Meiji Seika Pharma soutiendra l’accélération des innovations visant à relever les défis sanitaires mondiaux...
-
Meiji Seika Pharma investiert in den Global Health Security Fund der GHIC
TOKIO--(BUSINESS WIRE)--Meiji Seika Pharma Co., Ltd. (Hauptsitz: Tokio, Japan; Präsident und Geschäftsführer: Toshiaki Nagasato) gab heute bekannt, dass das Unternehmen sich zu einer Investition in den Global Health Security Fund (GHSF) verpflichtet hat, der von der Global Health Investment Corporation (GHIC), einer in New York ansässigen gemeinnützigen Organisation, gesponsert wird. Durch diese Investition wird Meiji Seika Pharma die Beschleunigung von Innovationen unterstützen, die sich mit k...
-
Riassunto: BeOne Medicines definisce uno standard per il controllo della malattia a lungo termine nella LLC con i dati a 78 mesi di BRUKINSA all'ASCO 2026
SAN CARLOS, Calif.--(BUSINESS WIRE)--BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), un'azienda oncologica a livello globale, sta portando avanti il paradigma terapeutico nella leucemia linfatica cronica (LLC) al Meeting annuale 2026 dell'American Society of Clinical Oncology (ASCO). Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare al tes...
-
BeOne Medicines estabelece padrão para controle de longo prazo da doença em LLC com dados de 78 meses de BRUKINSA no ASCO 2026
SAN CARLOS, Califórnia--(BUSINESS WIRE)--A BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), uma empresa global de oncologia, está avançando o paradigma de tratamento da leucemia linfocítica crônica (LLC) na Reunião Anual da Sociedade Americana de Oncologia Clínica (ASCO) de 2026. Com um extenso acompanhamento de longo prazo, o estudo SEQUOIA com BRUKINSA® (zanubrutinibe) reforça seu papel como o inibidor fundamental da BTK, demonstrando controle sustentado da doença ao longo de ano...
-
Eaton Vance Closed-End Funds Release Estimated Sources of Distributions
BOSTON--(BUSINESS WIRE)--The Eaton Vance closed-end funds listed below released today the estimated sources of their May distributions (each a “Fund”). This press release is issued as required by the Funds’ managed distribution plan (Plan) and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the implementation of the Plan to make monthly, as noted below, cash distributions to common shareholders, stated in terms of a fixed amount p...
-
GID Residential Partners Strengthens National Expansion With Boston Entry
NEW YORK--(BUSINESS WIRE)--GID, a vertically-integrated real estate owner, operator, developer and investor with $32.8 billion in assets under management, today announced the continued expansion of GID Residential Partners, its national development platform, with a strategic entry into the Boston market. The initiative will be led by industry veteran Chris Spendley, who joins the firm as Managing Director. Building on GID’s longstanding multifamily development experience, the growth within Bost...
-
エクサグリッド、「Network Computing Awards 2026」で5つの業界賞を受賞
マサチューセッツ州マールボロ--(BUSINESS WIRE)--(ビジネスワイヤ) -- ExaGrid®(エクサグリッド)は、ランサムウェア復旧に向けた最も包括的なセキュリティー機能とAI搭載リテンション・タイムロック機能を備えた階層型バックアップストレージを提供する、世界最大の独立系バックアップストレージベンダーです。同社は、Air-gapped Ransomware Recovery Product of the Year(エアギャップ型ランサムウェア復旧製品オブザイヤー)、Bench Tested Product of the Year(ベンチテスト製品オブザイヤー)、Company of the Year(企業オブザイヤー)、Data Protection Product of the Year(データ保護製品オブザイヤー)およびStorage Product of the Year(ストレージ製品オブザイヤー)を含む5つの業界賞を、Network Computing Awardsの授賞式において受賞したと発表しました。同授賞式は2026年5月21日にロンドンで開催されま...